- +1 858 909 0079
- +1 858 909 0057
- [email protected]
- +1 858 909 0079
- [email protected]
Cat# | Product Name | Swiss Prot# | Size | Price (US$) | Order |
PN0724 | Recombinant Protein-Human adenovirus D serotype 15 Early E3 50K glycoprotein (a.a.18 to 422) | Q91CB7 | 100 µg | 1195 | |
PN0725 | Recombinant Protein-Human adenovirus D serotype 8 20.1kDa protein (a.a.16 to 184) | B9A5C7 | 100 µg | 1195 | |
PN0726 | Recombinant Protein-Human adenovirus D serotype 8 E3A3gp 17.7k (a.a.22 to 158) | Q76C88 | 100 µg | 1195 | |
PN0727 | Recombinant Protein-Human adenovirus D serotype 8 100k 18.6 k (a.a.21 to 170) | Q76C92 | 100 µg | 1195 | |
PN0728 | Recombinant Protein-Human adenovirus D serotype 8 E3A2 16.0k (a.a.22 to 190) | Q76EL8 | 100 µg | 1195 | |
PN0729 | Recombinant Protein-Human adenovirus D serotype 8 PVIII (a.a.42 to 132) | Q76EM0 | 100 µg | 1195 | |
PN0730 | Recombinant Protein-Human adenovirus D serotype 8 17.5kDa protein (E3A1 gp17.6k) (a.a.18 to 157) | Q7TBH1 | 100 µg | 1195 | |
PN0731 | Recombinant Protein-Human adenovirus D serotype 8 22kDa protein (a.a.21 to 127) | B9A5C4 | 100 µg | 1195 | |
PN0732 | Recombinant Protein-Human adenovirus D serotype 9 Early E4 34 kDa protein (a.a.21 to 292) | P89083 | 100 µg | 1195 | |
PN0733 | Recombinant Protein-Human adenovirus D serotype 9 39.3 kDa fiber protein (a.a.21 to 362) | Q5TIY8 | 100 µg | 1195 | |
PN0734 | Recombinant Protein-Human adenovirus D serotype 9 E3 orf3 33.1 kDa protein (a.a.53 to 296) | Q5TIZ2 | 100 µg | 1195 | |
PN0735 | Recombinant Protein-Human adenovirus D serotype 9 E3 18.4 kDa protein (a.a.28 to 167) | Q5TIZ6 | 100 µg | 1195 | |
PN0736 | Recombinant Protein-Human adenovirus D serotype 9 E3 21.8 kDa protein (a.a.28 to 196) | Q5TIZ7 | 100 µg | 1195 | |
PN0737 | Recombinant Protein-Human adenovirus D serotype 9 L4 pVIII protein (a.a.36 to 227) | Q5TIZ9 | 100 µg | 1195 | |
PN0738 | Recombinant Protein-Human adenovirus D serotype 9 Major core protein L2 pVII (a.a.21 to 194) | Q5TJ08 | 100 µg | 1195 | |
PN0739 | Recombinant Protein-Human adenovirus D 42.2 kDa protein (a.a.28 to 374) | Q5TJ11 | 100 µg | 1195 | |
PN0740 | Recombinant Protein-Human adenovirus D serotype 9 E3 14.5 kDa protein (a.a.17 to 129) | Q9JFL8 | 100 µg | 1195 | |
PN0741 | Recombinant Protein-Human adenovirus D serotype 9 E1A 13S protein (a.a.51 to 133) | Q9YLA1 | 100 µg | 1195 | |
RPN0724 | cDNA-Human adenovirus D serotype 15 Early E3 50K glycoprotein (a.a.18 to 422) | Q91CB7 | 2 µg | 2020 | |
RPN0725 | cDNA-Human adenovirus D serotype 8 20.1kDa protein (a.a.16 to 184) | B9A5C7 | 2 µg | 840 | |
RPN0726 | cDNA-Human adenovirus D serotype 8 E3A3gp 17.7k (a.a.22 to 158) | Q76C88 | 2 µg | 800 | |
RPN0727 | cDNA-Human adenovirus D serotype 8 100k 18.6 k (a.a.21 to 170) | Q76C92 | 2 µg | 745 | |
RPN0728 | cDNA-Human adenovirus D serotype 8 E3A2 16.0k (a.a.22 to 190) | Q76EL8 | 2 µg | 840 | |
RPN0729 | cDNA-Human adenovirus D serotype 8 PVIII (a.a.42 to 132) | Q76EM0 | 2 µg | 800 | |
RPN0730 | cDNA-Human adenovirus D serotype 8 17.5kDa protein (E3A1 gp17.6k) (a.a.18 to 157) | Q7TBH1 | 2 µg | 800 | |
RPN0731 | cDNA-Human adenovirus D serotype 8 22kDa protein (a.a.21 to 127) | B9A5C4 | 2 µg | 800 | |
RPN0732 | cDNA-Human adenovirus D serotype 9 Early E4 34 kDa protein (a.a.21 to 292) | P89083 | 2 µg | 1355 | |
RPN0733 | cDNA-Human adenovirus D serotype 9 39.3 kDa fiber protein (a.a.21 to 362) | Q5TIY8 | 2 µg | 1705 | |
RPN0734 | cDNA-Human adenovirus D serotype 9 E3 orf3 33.1 kDa protein (a.a.53 to 296) | Q5TIZ2 | 2 µg | 1215 | |
RPN0735 | cDNA-Human adenovirus D serotype 9 E3 18.4 kDa protein (a.a.28 to 167) | Q5TIZ6 | 2 µg | 800 | |
RPN0736 | cDNA-Human adenovirus D serotype 9 E3 21.8 kDa protein (a.a.28 to 196) | Q5TIZ7 | 2 µg | 840 | |
RPN0737 | cDNA-Human adenovirus D serotype 9 L4 pVIII protein (a.a.36 to 227) | Q5TIZ9 | 2 µg | 955 | |
RPN0738 | cDNA-Human adenovirus D serotype 9 Major core protein L2 pVII (a.a.21 to 194) | Q5TJ08 | 2 µg | 865 | |
RPN0739 | cDNA-Human adenovirus D 42.2 kDa protein (a.a.28 to 374) | Q5TJ11 | 2 µg | 1730 | |
RPN0740 | cDNA-Human adenovirus D serotype 9 E3 14.5 kDa protein (a.a.17 to 129) | Q9JFL8 | 2 µg | 800 | |
RPN0741 | cDNA-Human adenovirus D serotype 9 E1A 13S protein (a.a.51 to 133) | Q9YLA1 | 2 µg | 800 |
Human adenovirus D cDNA and recombinant antigen
Human adenovirus D is a type of adenovirus that can cause a range of illnesses in humans, including respiratory infections, conjunctivitis, and gastroenteritis. Some adenovirus D strains can also cause more serious illnesses, such as meningitis or pneumonia. The virus spreads through close contact with an infected person or through contact with contaminated surfaces. There is no specific cure for adenovirus infections, but symptoms can be managed with rest, hydration, and over-the-counter medications. Like all adenoviruses, human adenovirus D can infect a wide range of host cells and cause a variety of symptoms depending on the host’s age, immune status, and the specific strain of the virus.
The human adenovirus D genome refers to the complete set of genetic information contained within the human adenovirus D virus. The adenovirus genome is composed of double-stranded DNA and encodes for a variety of viral proteins that allow the virus to infect host cells, replicate, and evade the host immune response. Understanding the adenovirus D genome is important for understanding the molecular biology of the virus and for developing new diagnostic tools and treatments for adenovirus D infections.
Adenovirus D genomes can be analyzed using a variety of techniques, including sequencing, reverse transcription-polymerase chain reaction (RT-PCR), and in situ hybridization. These techniques allow researchers to study the genetic diversity of the virus, identify virulence factors, and track the spread of different adenovirus D strains. With advances in technology, it is becoming increasingly easier to analyze the human adenovirus D genome and to gain insights into the biology of this important human pathogen.
Human adenovirus D is a type of adenovirus that can cause respiratory infections in humans. It contains several key proteins that help the virus infect host cells, replicate, and evade the immune system. Some notable proteins found in serotype 15 include the Early E3 50K glycoprotein. Serotype 8 contains multiple proteins, including a 20.1 kDa protein, E3A3gp 17.7kDa, E3A2 16.0 kDa, PVIII, 17.5 kDa, and 22 kDa. Serotype 9 also has several important proteins, such as Early E4 34 kDa, 39.3 kDa fiber, E3 orf3 33.1 kDa, E3 18.4 kDa, E3 21.8 kDa, L4 pVIII, L2 pVII, E3 14.5 kDa, and E1A 13S. Understanding the roles of these proteins is crucial for the development of effective treatments and vaccines against human adenovirus D.
The use of recombinant proteins/cDNA in academic research and therapeutic applications has skyrocketed. However, in heterologous expression systems, successful recombinant protein expression is dependent on a variety of factors, including codon preference, RNA secondary structure, and GC content. When compared to pre-optimization, more and more experimental results demonstrated that the expression level was dramatically increased, ranging from two to hundred times depending on the gene. Bioclone has created a proprietary technology platform that has resulted in the creation of over 6,000 artificially synthesized codon-optimized cDNA clones (cloned in E.coli expression Vector), which are ready for production of the recombinant proteins.
Get the Latest News and Updates by Email
6393 Nancy Ridge Dr. Suite A
San Diego, CA 92121 USA
Fax: +1-858-909-0057
Get the Latest News and Updates by Email
© 2023 Bioclone Inc. All Rights Reserved.
Magnetic Beads Make Things Simple